{"componentChunkName":"component---common-build-tags-template-js","path":"/tag/schizophrenia/","result":{"data":{"allArticle":{"edges":[{"node":{"id":"Article_2341-markdown","title":"CBD Helps Alleviate Symptoms of Schizophrenia","slug":"cbd-helps-alleviate-symptoms-of-schizophrenia","content":"Schizophrenia is a complicated psychiatric disorder that effects 1.1% of the world’s population. 3.5 million people in the United States have active schizophrenia, but many people may have the disease without even knowing it because symptoms normally do not develop until somewhere between the ages 16 and 25. The most common symptoms of schizophrenia are delusions, hallucinations, and chaotic behavior and speech. Schizophrenia can be extremely detrimental to the lives of people and it is believed that one third to one half of homeless individuals suffer from schizophrenia. \n\nFOLLOW US ON [FACEBOOK](https://www.facebook.com/pg/hellomdcompany/posts/) & [INSTAGRAM](https://www.instagram.com/hellomd_com/?hl=en)\n\n### Effective Treatments are Lacking\n\nThere is a lack of effective treatment options for people with schizophrenia and all of the options available require a constant administration of medication. Current treatments include a cocktail of antipsychotic medications, which are determined based on what symptoms are most prominent in the individual patient. There are many medications available to help with hallucinations and delusions, but there are not many to help with the cognitive symptoms of schizophrenia. Cannabis, however, may be able to help relieve some cognitive problems that can come from schizophrenia. \n\n### CBD Relieves Many Symptoms\n\nA recent rat modeled [study published in the the journal Nature](https://www.ncbi.nlm.nih.gov/pubmed/28230072) found that CBD derived from cannabis may help with cognitive impairment related to schizophrenia. The research was conducted at the Illawarra Health and Medical Research Institute (IHMRI) in New South Wales, Australia. In the study, rats were infected prenatally with polycytidilic acid. The acid helps replicate similar symptoms to psychiatric disorders like schizophrenia and produces a generation of mice with symptoms. Once born, the mice were treated using chronic CBD treatment and were tested on social interaction and cognitive function. \n\nRELATED: [CANNABIS MAY HELP PEOPLE WITH SCHIZOPHRENIA](https://www.hellomd.com/health-wellness/5952753e491da24423fed6a2/cannabis-may-help-people-with-schizophrenia)\n\nThe symptomatic mice were given 10 mg of CBD for three weeks and many factors were measured, including body weight and food and water intake. There were a plethora of tests conducted on the mice during and following their treatment with CBD. The tests were conducted to look at the effectiveness of the CBD at helping counteract some of the cognitive symptoms of schizophrenia and included T-maze tests, novel object recognition tests, and social interaction tests. \n\nThe study's lead author, Ashleigh Osborne, [said of the studies results](http://www.medicalnewstoday.com/articles/317768.php), “We found that CBD was able to restore recognition and working memory, as well as social behavior to normal levels. These findings are interesting because they suggest that CBD may be able to treat some of the symptoms of schizophrenia that are seemingly resistant to existing medications.\n\nIn addition, CBD treatment did not alter body weight or food intake, which are common side effects of antipsychotic drug treatment.” The effects that CBD had on the mice could indicate a major breakthrough in the world of schizophrenia treatment because it appears to achieve something that no other medications have been able to, including rebuilding cognitive potential and improving social interaction. \n\n### THC May Worsen Symptoms\n\nCannabis as a whole, however, may not be good for schizophrenia sufferers because THC is believed to potentially worsen the symptom of schizophrenia. Though THC can be very helpful for some medical conditions, it could be detrimental to sufferers of schizophrenia, whereas CBD may be extremely beneficial. The researchers also conducted a review of studies on the therapeutic value of CBD before conducting this recent rat modeled study, \"From this review, we found that CBD will not improve learning and memory in healthy brains, but may improve aspects of learning and memory in illnesses associated with cognitive impairment, including Alzheimer's disease, as well as neurological and neuro-inflammatory disorders,” [said Dr. Katrina Green](http://www.medicalnewstoday.com/articles/317768.php), one of the lead researchers on the recent study. \n\nThe review highlighted that cannabis does not have the same effects on people who have conditions and those who do not. Some of this reaction could potentially be tied to the idea of endocannabinoid deficiency, which hypothesizes that a lack of internally produced endocannabinoids could be linked to certain conditions, meaning that a better state of homeostasis can be achieved when the body is supplemented by cannabinoids from cannabis. People without a deficiency, however, could instead experience no positive attributes from the cannabinoids because their bodies are naturally in equilibrium.\n\n### Targeting Cognitive Functions \n\nMore research is necessary into why the cannabinoids seem to be effective at targeting cognitive problems related to schizophrenia, because currently there is no definitive answer. The researchers of the study hope to be able to conduct more studies and eventually a clinical trial to see if there would be similar effects on humans with schizophrenia as seen modeled in rats in this study. This study provides yet another look into how cannabis could potentially help a group of people who find it difficult to receive adequate medication for their condition. \n\nIf you are new to cannabis and want to learn more, take a look at our [Cannabis 101](https://www.hellomd.com/health-wellness/cannabis-101-your-quick-guide-to-medical-marijuana) post. [HelloMD](https://www.hellomd.com/) can help you get your medical marijuana recommendation; it's 100% online, private and efficient.  ","image":{"childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":1.3333333333333333,"src":"/static/ab928de5ae87cb9b929dc66e6b1167b9/14b42/161d96efc4b392a1a6c1c03c4fac0e5b.jpg","srcSet":"/static/ab928de5ae87cb9b929dc66e6b1167b9/f836f/161d96efc4b392a1a6c1c03c4fac0e5b.jpg 200w,\n/static/ab928de5ae87cb9b929dc66e6b1167b9/2244e/161d96efc4b392a1a6c1c03c4fac0e5b.jpg 400w,\n/static/ab928de5ae87cb9b929dc66e6b1167b9/14b42/161d96efc4b392a1a6c1c03c4fac0e5b.jpg 800w,\n/static/ab928de5ae87cb9b929dc66e6b1167b9/47498/161d96efc4b392a1a6c1c03c4fac0e5b.jpg 1200w,\n/static/ab928de5ae87cb9b929dc66e6b1167b9/54ac5/161d96efc4b392a1a6c1c03c4fac0e5b.jpg 1365w","srcWebp":"/static/ab928de5ae87cb9b929dc66e6b1167b9/58556/161d96efc4b392a1a6c1c03c4fac0e5b.webp","srcSetWebp":"/static/ab928de5ae87cb9b929dc66e6b1167b9/61e93/161d96efc4b392a1a6c1c03c4fac0e5b.webp 200w,\n/static/ab928de5ae87cb9b929dc66e6b1167b9/1f5c5/161d96efc4b392a1a6c1c03c4fac0e5b.webp 400w,\n/static/ab928de5ae87cb9b929dc66e6b1167b9/58556/161d96efc4b392a1a6c1c03c4fac0e5b.webp 800w,\n/static/ab928de5ae87cb9b929dc66e6b1167b9/99238/161d96efc4b392a1a6c1c03c4fac0e5b.webp 1200w,\n/static/ab928de5ae87cb9b929dc66e6b1167b9/5e0b8/161d96efc4b392a1a6c1c03c4fac0e5b.webp 1365w","sizes":"(max-width: 800px) 100vw, 800px"}}}}},{"node":{"id":"Article_2251-markdown","title":"Cannabis May Help People With Schizophrenia","slug":"cannabis-may-help-people-with-schizophrenia","content":"Schizophrenia is a complicated psychiatric disorder that effects 1.1% of the world’s population. 3.5 million people in the United States have active schizophrenia, but many people may have the disease without even knowing it because symptoms normally do not develop until somewhere between the ages sixteen and twenty-five. The most common symptoms of schizophrenia are delusions, hallucinations, and chaotic behavior and speech. Schizophrenia can be extremely detrimental to the lives of people and it is believed that one third to one half of homeless individuals suffer from schizophrenia. \r\n\r\n### Lack of Effective Treatments\r\n\r\nThere is a lack of effective treatment options for people with schizophrenia and all of the options available require a constant administration of medication. Current treatments include a cocktail of antipsychotic medications, which are determined based on what symptoms are most prominent in the individual patient. There are many medications available to help with hallucinations and delusions, but there are not many to help with the cognitive symptoms of schizophrenia. Cannabis, however, may be able to help relieve some cognitive problems that can come from schizophrenia. \r\n\r\n### CBD May Help\r\n\r\nA recent rat modeled [study published in the the journal Nature](https://www.ncbi.nlm.nih.gov/pubmed/28230072) found that CBD derived from cannabis may help with cognitive impairment related to schizophrenia. The research was conducted at the Illawarra Health and Medical Research Institute (IHMRI) in New South Wales, Australia. In the study, rats were infected prenatally with polycytidilic acid. The acid helps replicate similar symptoms to psychiatric disorders like schizophrenia and produces a generation of mice with symptoms. Once born, the mice were treated using chronic CBD treatment and were tested on social interaction and cognitive function. \r\n\r\nFOLLOW US ON [FACEBOOK](https://www.facebook.com/pg/hellomdcompany/posts/) & [INSTAGRAM](https://www.instagram.com/hellomd_com/?hl=en)\r\n\r\nThe symptomatic mice were given 10 mg of CBD for three weeks and many factors were measured, including body weight and food and water intake. There were a plethora of tests conducted on the mice during and following their treatment with CBD. The tests were conducted to look at the effectiveness of the CBD at helping counteract some of the cognitive symptoms of schizophrenia and included T-maze tests, novel object recognition tests, and social interaction tests. \r\n\r\nThe study's lead author, Ashleigh Osborne, [said of the studies results](http://www.medicalnewstoday.com/articles/317768.php), “We found that CBD was able to restore recognition and working memory, as well as social behavior to normal levels. These findings are interesting because they suggest that CBD may be able to treat some of the symptoms of schizophrenia that are seemingly resistant to existing medications. In addition, CBD treatment did not alter body weight or food intake, which are common side effects of antipsychotic drug treatment.” The effects that CBD had on the mice could indicate a major breakthrough in the world of schizophrenia treatment because it appears to achieve something that no other medications have been able to, including rebuilding cognitive potential and improving social interaction. \r\n\r\n### THC May Worsen Symptoms\r\n\r\nCannabis as a whole, however, may not be good for schizophrenia sufferers because THC is believed to potentially worsen the symptom of schizophrenia. Though THC can be very helpful for some medical conditions, it could be detrimental to sufferers of schizophrenia, whereas CBD may be extremely beneficial. The researchers also conducted a review of studies on the therapeutic value of CBD before conducting this recent rat modeled study, \"From this review, we found that CBD will not improve learning and memory in healthy brains, but may improve aspects of learning and memory in illnesses associated with cognitive impairment, including Alzheimer's disease, as well as neurological and neuro-inflammatory disorders,” [said Dr. Katrina Green](http://www.medicalnewstoday.com/articles/317768.php), one of the lead researchers on the recent study. \r\n\r\nThe review highlighted that cannabis does not have the same effects on people who have conditions and those who do not. Some of this reaction could potentially be tied to the idea of endocannabinoid deficiency, which hypothesizes that a lack of internally produced endocannabinoids could be linked to certain conditions, meaning that a better state of homeostasis can be achieved when the body is supplemented by cannabinoids from cannabis. People without a deficiency, however, could instead experience no positive attributes from the cannabinoids because their bodies are naturally in equilibrium. \r\n\r\nMore research is necessary into why the cannabinoids seem to be effective at targeting cognitive problems related to schizophrenia, because currently there is no definitive answer.  The researchers of the study hope to be able to conduct more studies and eventually a clinical trial to see if there would be similar effects on humans with schizophrenia as seen modeled in rats in this study. This study provides yet another look into how cannabis could potentially help a group of people who find it difficult to receive adequate medication for their condition. \r\n\r\nIf you are new to cannabis and want to learn more, take a look at our [Cannabis 101](https://www.hellomd.com/health-wellness/cannabis-101-your-quick-guide-to-medical-marijuana) post. [HelloMD](https://www.hellomd.com/) can help you get your medical marijuana recommendation; it's 100% online, private and efficient.  ","image":{"childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":1.3333333333333333,"src":"/static/8ca8739589fe493ba2c588fd3913b8d9/14b42/74e8b1d9dfcfa45f38e3818b6bacdb9e.jpg","srcSet":"/static/8ca8739589fe493ba2c588fd3913b8d9/f836f/74e8b1d9dfcfa45f38e3818b6bacdb9e.jpg 200w,\n/static/8ca8739589fe493ba2c588fd3913b8d9/2244e/74e8b1d9dfcfa45f38e3818b6bacdb9e.jpg 400w,\n/static/8ca8739589fe493ba2c588fd3913b8d9/14b42/74e8b1d9dfcfa45f38e3818b6bacdb9e.jpg 800w,\n/static/8ca8739589fe493ba2c588fd3913b8d9/47498/74e8b1d9dfcfa45f38e3818b6bacdb9e.jpg 1200w,\n/static/8ca8739589fe493ba2c588fd3913b8d9/54ac5/74e8b1d9dfcfa45f38e3818b6bacdb9e.jpg 1365w","srcWebp":"/static/8ca8739589fe493ba2c588fd3913b8d9/58556/74e8b1d9dfcfa45f38e3818b6bacdb9e.webp","srcSetWebp":"/static/8ca8739589fe493ba2c588fd3913b8d9/61e93/74e8b1d9dfcfa45f38e3818b6bacdb9e.webp 200w,\n/static/8ca8739589fe493ba2c588fd3913b8d9/1f5c5/74e8b1d9dfcfa45f38e3818b6bacdb9e.webp 400w,\n/static/8ca8739589fe493ba2c588fd3913b8d9/58556/74e8b1d9dfcfa45f38e3818b6bacdb9e.webp 800w,\n/static/8ca8739589fe493ba2c588fd3913b8d9/99238/74e8b1d9dfcfa45f38e3818b6bacdb9e.webp 1200w,\n/static/8ca8739589fe493ba2c588fd3913b8d9/5e0b8/74e8b1d9dfcfa45f38e3818b6bacdb9e.webp 1365w","sizes":"(max-width: 800px) 100vw, 800px"}}}}},{"node":{"id":"Article_2226-markdown","title":"CBD: An Alternative to Anti-Psychotic Medicine","slug":"cbd-an-alternative-to-anti-psychotic-medicine","content":"The benefits of medicinal cannabis are numerous and far reaching. From pain relief and nausea to [new research](http://www.ncbi.nlm.nih.gov/pubmed/22716160) suggesting a firm link between cancer cell death and cannabis, it is becoming more evident that cannabis has a large role to play in medicine. A significant part of marijuana's efficacy is due to the numerous medicinal properties of cannabidiol (CBD), one of the cannabinoid compounds found within cannabis. \n\nCBD is an analgesic and an anti-inflammatory, and it also happens to be non-psychoactive. As both attitudes and written laws change around marijuana, more and more research is coming to light that highlights its numerous medical benefits. One particular area of interest is in CBD as a potential anti-psychotic medication, especially for those suffering from schizophrenia. \n\n### How Mainstream Medicine Often Fails Patients\n\nAlthough traditional medicines like Risperdol and Clozapine have found mainstream success managing the symptoms associated with schizophrenia, many bring with them a list of discomforting and even in some cases, debilitating side effects. A short list of the more common side effects of Abilify (aripiprazole), a popular atypical-antipsychotic medicine originally designed for patients with schizophrenia (and now prescribed for many mental/mood disorders), showcases just how many additional ways a patient can find discomfort through one of the only means of finding relief from his or her disorder: \n\n* Difficulty with speaking\n* Drooling\n* Loss of balance control\n* Muscle trembling, jerking, or stiffness\n* Restlessness\n* Shuffling walk\n* Stiffness of the limbs\n* Twisting movements of the body\n* Uncontrolled movements, especially of the face, neck, and back\n\nPatients must exercise additional caution when using these medications as some of the rare (meaning between 1 in 1,000 and 1 in 10,000 may encounter these negative aspects of the drug over their lifetime) side effects, despite their low prevalence, are extremely serious. A few short examples of the rare rare effects of Abilify are: sudden loss of consciousness, loss of bladder control, and convulsions. When we look back at the common side effects and consider that between 1 in 10 to 1 in 100 are expected to experience these unpleasant effects, the picture becomes even more clear. \n\n### How CBD Can Help Those Suffering From Psychosis\n\nNew research is now beginning to shine a spotlight on CBD as a potential alternative to anti-psychotic medication. “A Critical Review of the Anti-Psychotic Effects of Cannabidiol: 30 Years of a Translational Investigation,” published by Bentham Science Publishers in 2012, gives a detailed look into 24 complimentary studies that tested CBD as an anti-psychotic medication in animal and human patients.\n\nThe outcome of the review led researchers to conclude that “the results discussed above clearly indicate that CBD behaves in preclinical and clinical studies as an atypical anti-psychotic, improving psychotic-like symptoms in doses that do not impair motor function” and that “these results support the idea that CBD may be a future therapeutic option in psychosis, in general and in schizophrenia, in particular.” \n\nResearch like this is very motivating news for patients who still have only a few options when trying to find relief from their disorder, especially considering that CBD have shown repeatedly to have no proven side effects, other than fatigue in extreme cases.\n\nAlthough a general consensus has not yet been reached on whether CBD has a future as a frontline option for patients suffering from a form of psychosis, the new attention reviews like this will give to CBD will hopefully spur new research into this potentially life-altering medication. \n","image":{"childImageSharp":{"fluid":{"base64":"data:image/png;base64,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","aspectRatio":1.3333333333333333,"src":"/static/26d3241d3bd672746142a8ec8cb41a45/ee604/790f9597bbea915674c6ee6cf773ada3.png","srcSet":"/static/26d3241d3bd672746142a8ec8cb41a45/69585/790f9597bbea915674c6ee6cf773ada3.png 200w,\n/static/26d3241d3bd672746142a8ec8cb41a45/497c6/790f9597bbea915674c6ee6cf773ada3.png 400w,\n/static/26d3241d3bd672746142a8ec8cb41a45/ee604/790f9597bbea915674c6ee6cf773ada3.png 800w,\n/static/26d3241d3bd672746142a8ec8cb41a45/f3583/790f9597bbea915674c6ee6cf773ada3.png 1200w,\n/static/26d3241d3bd672746142a8ec8cb41a45/f90fa/790f9597bbea915674c6ee6cf773ada3.png 1365w","srcWebp":"/static/26d3241d3bd672746142a8ec8cb41a45/58556/790f9597bbea915674c6ee6cf773ada3.webp","srcSetWebp":"/static/26d3241d3bd672746142a8ec8cb41a45/61e93/790f9597bbea915674c6ee6cf773ada3.webp 200w,\n/static/26d3241d3bd672746142a8ec8cb41a45/1f5c5/790f9597bbea915674c6ee6cf773ada3.webp 400w,\n/static/26d3241d3bd672746142a8ec8cb41a45/58556/790f9597bbea915674c6ee6cf773ada3.webp 800w,\n/static/26d3241d3bd672746142a8ec8cb41a45/99238/790f9597bbea915674c6ee6cf773ada3.webp 1200w,\n/static/26d3241d3bd672746142a8ec8cb41a45/5e0b8/790f9597bbea915674c6ee6cf773ada3.webp 1365w","sizes":"(max-width: 800px) 100vw, 800px"}}}}}]}},"pageContext":{"limit":12,"skip":0,"numPages":1,"currentPage":1,"id":5721,"name":"Schizophrenia","slug":"schizophrenia","country":"US"}},"staticQueryHashes":["3949754563","4179947113","4202924991"]}